CentreStone Ventures

CentreStone Ventures is a life sciences-focused private venture capital fund founded in 2004 and based in Winnipeg, Manitoba, Canada — geographically at the center of North America. The firm invests in companies developing early-stage therapeutics, medical devices, diagnostics, and novel drug delivery methods, targeting opportunities with clear unmet clinical needs, solid intellectual property foundations, and the potential to achieve market leadership. CentreStone deploys checks of $500,000 to $3 million at the Seed and Series A stages. Across seven portfolio investments, the firm has achieved three IPOs and one acquisition — a strong exit rate relative to portfolio size that reflects a selective, high-conviction approach to company selection. The small team of three manages a focused book of life sciences companies, prioritizing depth of engagement over breadth of portfolio. The firm appears to be in portfolio management mode rather than actively making new investments, with the most recent investment recorded in 2018. During its active period, CentreStone played a niche institutional role in Canada's healthcare and biotech ecosystem — channeling specialized venture capital into a region that generates significant life sciences research through its university and medical community but has historically had limited access to dedicated early-stage health technology investment capital.